Data security, diversity debated at precision medicine 'Super Bowl'
This article was originally published in Scrip
Executive Summary
At what was characterized as an event harder to get into than the "Super Bowl," scientists from multiple sectors, including academic institutions, government agencies, mobile technology and the drug and device industries, along with other stakeholders, like patient advocates, debated the direction the US should take in building a one-million person research cohort under President Barack Obama's personalized medicine initiative.